---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-015153"
form_type: "8-K/A"
ticker: null
cik: "0001261249"
company_name: "AGILE THERAPEUTICS INC"
filed_at: "2023-08-22T23:59:59+00:00"
generated_at: "2026-06-11T05:22:14.070504+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Agile Therapeutics appoints Scott Coiante as CFO; discloses employment terms and CAO departure

## Summary
- Scott Coiante appointed SVP, CFO & Treasurer effective Aug 16, 2023; base salary $430K, target bonus 45%.
- Coiante receives inducement grant of 20,000 RSUs vesting over 4 years; acceleration upon change of control.
- Severance: 12 months base salary (non-CoC) or 18 months lump sum plus bonus and equity acceleration (CoC).
- Jason Butch separated as CAO effective Aug 15, 2023; receives 6 months base salary and benefits.
- Coiante subject to 18-month non-compete and perpetual confidentiality covenants.

## SEC filing metadata
- accession: 0001558370-23-015153
- form_type: 8-K/A
- cik: 0001261249
- company_name: AGILE THERAPEUTICS INC
- filed_at: 2023-08-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1261249/000155837023015153/0001558370-23-015153-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1261249/000155837023015153/agrx-20230621x8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-015153
- JSON: https://secwatch.observer/filing/0001558370-23-015153.json
- Plain text: https://secwatch.observer/filing/0001558370-23-015153.txt

## Key facts
- Executive change
  Jason Butch departed as Chief Accounting Officer at AGILE THERAPEUTICS INC.
  - Action: separated
  - Role: Chief Accounting Officer
  source text: the Company and Jason Butch came to a mutual agreement pursuant to which Mr. Butch separated from service as the Chief Accounting Officer of the Company, effective August 15, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1261249/000155837023015153/0001558370-23-015153-index.htm
- Executive change
  Scott Coiante was appointed as Senior Vice President, Chief Financial Officer and Treasurer at AGILE THERAPEUTICS INC.
  - Action: appointed
  - Role: Senior Vice President, Chief Financial Officer and Treasurer
  source text: appointed Scott Coiante to serve as the Company’s Senior Vice President, Chief Financial Officer and Treasurer, effective August 16, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1261249/000155837023015153/0001558370-23-015153-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.